Financials GeneTouch Corporation

Equities

6813

TW0006813009

Electronic Equipment & Parts

End-of-day quote Taipei Exchange 18:00:00 2024-06-12 EDT 5-day change 1st Jan Change
5 TWD -9.91% Intraday chart for GeneTouch Corporation -.--% -71.75%

Valuation

Fiscal Period: December 2020 2021 2022 2023
Capitalization 1 231.6 178.3 228.3 353.8
Enterprise Value (EV) 1 241.8 275.6 337.6 396.2
P/E ratio 42.5 x 14.1 x 353 x -4.71 x
Yield - - - -
Capitalization / Revenue 1.21 x 0.61 x 0.81 x 1.85 x
EV / Revenue 1.26 x 0.94 x 1.19 x 2.08 x
EV / EBITDA -24 x 18.1 x 56.7 x -6.62 x
EV / FCF -6.28 x -3.06 x -9.54 x 23.3 x
FCF Yield -15.9% -32.6% -10.5% 4.3%
Price to Book 2.81 x 1.87 x 1.64 x 2.41 x
Nbr of stocks (in thousands) 12,688 12,688 16,188 19,988
Reference price 2 18.25 14.05 14.10 17.70
Announcement Date 21-04-23 22-04-20 23-04-17 24-04-30
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 174.7 119.3 192 294 282.6 190.9
EBITDA 1 5.495 -29.1 -10.06 15.23 5.954 -59.82
EBIT 1 1.806 -31.09 -12.57 12.68 1.738 -65.87
Operating Margin 1.03% -26.06% -6.55% 4.32% 0.62% -34.5%
Earnings before Tax (EBT) 1 2.834 -31.93 3.423 12.69 0.59 -68.16
Net income 1 2.834 -31.9 3.423 12.69 0.59 -68.16
Net margin 1.62% -26.74% 1.78% 4.32% 0.21% -35.7%
EPS 2 0.4700 -5.860 0.4292 1.000 0.0400 -3.761
Free Cash Flow 1 -13.1 12.23 -38.51 -89.95 -35.4 17.02
FCF margin -7.5% 10.25% -20.06% -30.6% -12.53% 8.92%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 20-10-16 21-04-23 21-04-23 22-04-20 23-04-17 24-04-30
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 14.8 27.7 10.2 97.3 109 42.4
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 2.694 x -0.9508 x -1.016 x 6.389 x 18.37 x -0.7087 x
Free Cash Flow 1 -13.1 12.2 -38.5 -89.9 -35.4 17
ROE (net income / shareholders' equity) 4.31% -115% 6.86% 14.3% 0.5% -47.7%
ROA (Net income/ Total Assets) 0.85% -17.6% -4.51% 2.67% 0.31% -11.2%
Assets 1 331.7 181.6 -75.9 476.3 192.4 606.6
Book Value Per Share 2 7.080 3.150 6.500 7.500 8.590 7.350
Cash Flow per Share 2 4.690 6.580 5.550 6.250 4.460 3.900
Capex - 0.23 2.99 0.28 13.9 5.77
Capex / Sales - 0.19% 1.56% 0.09% 4.9% 3.02%
Announcement Date 20-10-16 21-04-23 21-04-23 22-04-20 23-04-17 24-04-30
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. 6813 Stock
  4. Financials GeneTouch Corporation